The AHA asked federal officials Monday to investigate whether five drugmakers engaged in anticompetitive practices while seeking to implement 340B rebate models.

Hospital Group Asks FTC, DOJ to Investigate Drugmakers’ Potential ‘Anticompetitive’ Efforts to Impose 340B Rebate Models

September 9, 2025 Shannon Young, Associate Editor/Senior Writer Views

A national hospital trade group urged federal officials Monday to investigate whether five major drugmakers engaged in anticompetitive practices while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Hospital Group Asks FTC, DOJ to Investigate Drugmakers’ Potential ‘Anticompetitive’ Efforts to Impose 340B Rebate Models

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Hospital Group Asks FTC, DOJ to Investigate Drugmakers’ Potential ‘Anticompetitive’ Efforts to Impose 340B Rebate Models

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Staff Email

Site Footer Live